跳至主要内容
临床试验/NCT07832695
NCT07832695招募中不适用

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS)-Primed Self-controlled Practice on Motor Behavior, Psychosocial Functioning, and Neurophysiological Mechanisms in People With Parkinson's Disease

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2026年9月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
1
主要终点
Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

研究概览

简要总结

Parkinson's disease (PD) is commonly associated with impaired motor learning and reduced motivation, both of which can negatively influence rehabilitation outcomes. Prior cross-sectional evidence suggests that providing individuals with PD self-controlled access to training parameters enhances motor learning, increases motivation, and facilitates cognitive processing. However, the effects of self-controlled practice implemented across repeated training sessions remain underexplored. Moreover, given that dysfunction of fronto-striatal circuits in PD may limit the neuroplastic response to motor training alone, adjunctive neuromodulatory priming approaches such as repetitive transcranial magnetic stimulation (rTMS) may be required to optimize therapeutic efficacy. To date, it remains unclear whether rTMS priming combined with self-controlled motor training yields superior clinical benefits, and whether stimulation of different cortical targets produces differential effects. In particular, the dorsolateral prefrontal cortex (DLPFC), a key region involved in cognitive control and motivation, may offer distinct therapeutic effects compared with stimulation of the primary motor cortex (M1). This study aims to investigate the effects of rTMS priming over the DLPFC or M1, followed by self-controlled motor training, in individuals with PD, and to compare these effects with a sham stimulation condition.

This single-blinded, randomized control trial will recruit 90 individuals with PD, who will be matched into 45 pairs and randomly assigned to one of three stimulation conditions: DLPFC, M1, or sham. Within each pair, one participant will be allocated to a self-controlled practice condition, and the other to a yoked (paired-control) condition that receives identical training content determined by their matched counterpart. Each participant will undergo 12 intervention sessions. In each session, rTMS will be applied first as a priming intervention, followed immediately by 45 minutes of standardized physical therapy-based motor training. For the DLPFC group, stimulation will target the left DLPFC; for the M1 group, stimulation will be applied over the M1 contralateral to the more affected limb; and for the sham condition, the coil will be rotated 90 degrees to mimic stimulation without effective cortical activation. During the training phase, participants in the self-controlled condition will be allowed to select aspects of their practice content, whereas yoked participants will follow the corresponding selections made by their matched partner.

The primary outcome measure is the Unified Parkinson's Disease Rating Scale (UPDRS). Secondary outcomes include assessments of cognitive function, apathy, non-motor symptoms, gait performance, balance, functional mobility, falls efficacy, and quality of life. Neurophysiological outcomes will be assessed using single- and paired-pulse TMS to evaluate corticospinal excitability and cortico-cortical connectivity, particularly between DLPFC and M1 networks. All assessments will be conducted in the medication-on state by blinded evaluators at baseline, immediately post-intervention, and at one-month follow-up. Data will be analyzed using mixed-effects repeated-measures ANOVA to examine group-by-time interactions and intervention effects. This study seeks to determine whether rTMS priming over cognitive-control versus motor networks differentially enhances the efficacy of self-controlled motor training, and whether such combined interventions can induce sustained improvements in motor and non-motor outcomes in PD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed of PD by neurologists and age above 18 years old
  • able to follow the researcher's instruction (the Montreal Cognitive Assessment ≥ 24)
  • able to stand and walk independently for 10 minutes with or without assistive devices

排除标准

  • have neurological disorders other than PD (e.g., Parkinson plus syndrome, cognitive impairment, dementia, stroke)
  • have contraindications to receive TMS, such as a pacemaker or deep brain stimulator implanted in the body
  • a self-history of seizure or a family history of epilepsy
  • pregnancy
  • unstable medical conditions that is not under control

研究组 & 干预措施

M1-yoked

Experimental

干预措施: Physical therapy (Behavioral)

DLPFC-self

Experimental

干预措施: Repetitive Transcranial Magnetic Stimulation (rTMS) (Device)

DLPFC-self

Experimental

干预措施: Physical therapy (Behavioral)

DLPFC-yoked

Experimental

干预措施: Repetitive Transcranial Magnetic Stimulation (rTMS) (Device)

DLPFC-yoked

Experimental

干预措施: Physical therapy (Behavioral)

M1-self

Experimental

干预措施: Repetitive Transcranial Magnetic Stimulation (rTMS) (Device)

M1-self

Experimental

干预措施: Physical therapy (Behavioral)

M1-yoked

Experimental

干预措施: Repetitive Transcranial Magnetic Stimulation (rTMS) (Device)

Sham-self

Sham Comparator

干预措施: Repetitive Transcranial Magnetic Stimulation (rTMS) (Device)

Sham-self

Sham Comparator

干预措施: Physical therapy (Behavioral)

Sham-yoked

Sham Comparator

干预措施: Repetitive Transcranial Magnetic Stimulation (rTMS) (Device)

Sham-yoked

Sham Comparator

干预措施: Physical therapy (Behavioral)

结局指标

主要结局

Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)

时间窗: Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks)

The MDS-UPDRS is currently the gold-standard scale used in the clinics as well as research to determine the disease severity of PD. The MDS-UPDRS contains four parts: (1) non-motor aspects of experiences of daily living, (2) motor aspects of experiences of daily living, (3) motor examination, and (4) motor complications. Each item is scored from 0 (no symptom) to 4 (most severe symptom), and the total score range for the MDS-UPDRS is from 0 to 260 with a higher score indicates greater disease severity.

次要结局

  • Gait performances(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • New freezing of gait questionnaire (NFOG-Q)(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • 5-time sit to stand test (5TSTS)(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Montreal cognitive assessment (MoCA)(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Short-form Lille apathy rating scale (LARS)(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Non-motor symptoms scale for Parkinson's disease (NMSS)(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Timed up and go (TUG) test(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Mini balance evaluation systems test (Mini-BESTest)(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Activities-Specific Balance Confidence (ABC) scale(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Parkinson's Disease Questionnaire-39 (PDQ-39)(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Motivation questionnaire(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Corticomotor excitability(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))
  • Cortico-cortical connectivity(Three time points: pre-test (before intervention, 0 week), post-test (after all intervention sessions, up to 4 weeks), follow-up test (one month after intervention, up to 8 weeks))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验